Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
13,69 USD | +0,81% | +2,70% | -36,83% |
26/04 | SAGE THERAPEUTICS, INC. : rating Neutral da Truist Securities | ZM |
25/04 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
Attività
Numero di dipendenti: 487
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Medicines
100,0
%
| 8 | 100,0 % | 86 | 100,0 % | +1.024,84% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 8 | 100,0 % | 86 | 100,0 % | +1.024,84% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Barry Greene
CEO | Chief Executive Officer | 60 | 01/10/20 |
Steven Paul
FOU | Founder | 73 | 16/04/10 |
Kimi Iguchi
DFI | Director of Finance/CFO | 61 | 01/03/13 |
Mike Quirk
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/14 |
Laura Gault
CTO | Chief Tech/Sci/R&D Officer | - | 31/10/22 |
Matt Lasmanis
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/20 |
Amy Schacterle
COO | Chief Operating Officer | - | 13/02/15 |
Jeff Jonas
BRD | Director/Board Member | 71 | 14/08/13 |
Tammy J. Phinney
LAW | General Counsel | - | 01/08/20 |
Vanessa Procter
PRN | Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 14/08/13 |
Steven Paul
FOU | Founder | 73 | 16/04/10 |
Barry Greene
CEO | Chief Executive Officer | 60 | 01/10/20 |
Jim Frates
BRD | Director/Board Member | 56 | 01/05/14 |
Michael Cola
BRD | Director/Board Member | 64 | 11/09/14 |
Geno Germano
CHM | Chairman | 63 | 19/07/16 |
Director/Board Member | 67 | 23/01/19 | |
Director/Board Member | 62 | 23/01/19 | |
Jessica Federer
BRD | Director/Board Member | - | 15/03/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 60 185 064 | 52 601 761 ( 87,40 %) | 3 033 ( 0,005039 %) | 87,40 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-36,83% | 824 Mln | |
-2,31% | 103 Mrd | |
+0,56% | 95,28 Mrd | |
+1,69% | 22,15 Mrd | |
-17,37% | 21,02 Mrd | |
-9,30% | 18,15 Mrd | |
-41,01% | 16,74 Mrd | |
-14,85% | 16,05 Mrd | |
+3,21% | 13,68 Mrd | |
+33,54% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione SAGE
- Società Sage Therapeutics, Inc.